‘Carbon-Monoxide-Releasing Molecule-2 (CORM-2)’ Is a Misnomer: Ruthenium Toxicity, Not CO Release, Accounts for Its Antimicrobial Effects
Carbon monoxide (CO)-releasing molecules (CORMs) are used to deliver CO, a biological ‘gasotransmitter’, in biological chemistry and biomedicine. CORMs kill bacteria in culture and in animal models, but are reportedly benign towards mammalian cells. CORM-2 (tricarbonyldichlororuthenium(II) dimer, Ru...
Main Authors: | Hannah M. Southam, Michael P. Williamson, Jonathan A. Chapman, Rhiannon L. Lyon, Clare R. Trevitt, Peter J. F. Henderson, Robert K. Poole |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-06-01
|
Series: | Antioxidants |
Subjects: | |
Online Access: | https://www.mdpi.com/2076-3921/10/6/915 |
Similar Items
-
Carbon Monoxide Therapy Using Hybrid Carbon Monoxide-Releasing/Nrf2-Inducing Molecules through a Neuroprotective Lens
by: Flavia Cavicchioli, et al.
Published: (2021-07-01) -
The Antimicrobial Activity of a Carbon Monoxide Releasing Molecule (EBOR-CORM-1) Is Shaped by Intraspecific Variation within Pseudomonas aeruginosa Populations
by: Lindsey Flanagan, et al.
Published: (2018-02-01) -
The donor of carbon monoxide (CORM-2) affects the level of serum immunoglobulins and the state of the bone marrow during the immune response in mice
by: S. P. Beschasnyi, et al.
Published: (2020-11-01) -
Induction of Heme Oxygenase By a Carbon Monoxide-Releasing Molecule
by: Kulina, Robert Andrew
Published: (2007) -
Different design of enzyme-triggered CO-releasing molecules (ET-CORMs) reveals quantitative differences in biological activities in terms of toxicity and inflammation
by: E. Stamellou, et al.
Published: (2014-01-01)